Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Research presented at the European Respiratory Society Congress reveals that the GLP-1 drug semaglutide may lower exacerbation rates in asthma and COPD patients, suggesting benefits beyond blood sugar control. Semaglutide, the GLP-1 drug used to treat type 2 diabetes and…
Most adults with type 2 diabetes and atherosclerotic cardiovascular disease are not receiving two key drug classes proven to protect the heart, with significant disparities linked to sex and insurance status highlighted in recent research. Most adults with type 2…
A woman with PCOS has experienced significant health complications, including diabetes and stroke, underscoring the need for ongoing monitoring of women and their children with the condition, as highlighted by the Chinese University of Hong Kong. A woman who struggled…
New research highlights the complex role of mitochondrial impairment in diabetic kidney disease, revealing diverse molecular patterns and promising therapeutic avenues, including natural compounds and targeted drugs, with a call for more clinical studies. Researchers say mitochondrial failure sits at…
A recent study suggests that focusing on physical activity and blood sugar regulation in midlife can significantly slow cognitive decline among adults, with implications for dementia prevention. A midlife focus on exercise and blood sugar control may help slow cognitive…
A Grafton exercise physiology practice introduces tailored physical activity programmes designed to improve blood sugar management and long-term health for people living with Type 1 and Type 2 diabetes, supported by current medical research. Exercise and diabetes management are closely…
BioLife has secured a US patent for its groundbreaking effervescent oral peptide delivery technology, potentially transforming treatments for obesity and diabetes as demand for oral therapies rises. BioLife has secured a US patent for an effervescent oral peptide delivery platform…
The Fifth Circuit has upheld the FDA’s decision to remove semaglutide and tirzepatide from the federal shortage list, limiting mass compounding of popular diabetes and weight-loss drugs and reinforcing manufacturer supply data as decisive. The Fifth Circuit has upheld the…
Recent research suggests that the genetic underpinnings of type 1 diabetes are more diverse than previously thought, with implications for risk assessment and personalised prevention strategies. A new analysis from researchers at the University of Exeter and the University of…
Routine kidney screenings using tests like eGFR and urine albumin are crucial for early detection of damage in diabetes patients, with experts emphasising the need for regular monitoring to prevent progression to kidney failure. Kidney disease is one of the…
Banda Aceh’s health authorities are intensifying screening programs amid rising cases of hypertension and diabetes, highlighting the growing need for early diagnosis to prevent serious complications. Hypertension is the most frequently recorded non-communicable disease in Banda Aceh, with diabetes mellitus…
The identical active ingredient, tirzepatide, is marketed under different brands, Mounjaro and Zepbound, depending on their approved use for diabetes or weight loss, complicating access and pricing for patients. Mounjaro has become one of the most talked-about injections in medicine,…
